Auris Medical Holding AG | CIK:0001601936 | 3

  • Filed: 3/22/2018
  • Entity registrant name: Auris Medical Holding AG (CIK: 0001601936)
  • Generator: Workiva (WebFilings)
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1601936/000160193618000007/0001601936-18-000007-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1601936/000160193618000007/ears-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001601936
  • Open this page in separate window: Click

    • ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory

    Finance income and finance expense

     
    2017
     
    2016
     
    2015
    Interest income
    53,570

     
    67,565

     
    36,562

    Net foreign currency exchange gain
    1,912,681

     
    843,950

     
    1,806,206

    Revaluation gain from derivative financial instruments
    3,372,186

     
    291,048

     
    —

    Total finance income
    5,338,437

     
    1,202,563

     
    1,842,768

    Interest expense (incl. Bank charges)
    1,640,394

     
    828,547

     
    7,985

    Net foreign currency exchange loss
    2,737,273

     
    944,047

     
    662,100

    Total finance expense
    4,377,667

     
    1,772,594

     
    670,085

    Finance income/(expense), net
    960,770

     
    (570,031
    )
     
    1,172,683

     
     
     
     
     
     




    In 2017, net foreign currency exchange gains contain translation gains of CHF 1,315,029 (2016: CHF 396,665; 2015: CHF 1,154,513) which arose on the Company’s USD and EUR denominated cash and cash equivalents. In 2017, interest expenses include interest paid to Hercules Capital, Inc. under the Loan and Security Agreement in an amount of CHF 1,182,369 (2016: CHF 546,170; 2015: CHF 0).